Loureiro JA

ORCID: 0000-0002-9841-3967 · 1 paper in corpus

2025

Advancing Brain Targeting: Cost-Effective Surface-Modified Nanoparticles for Faster Market Entry.

Pharmaceutics ·doi:10.3390/pharmaceutics17050661

Background/Objectives: The blood-brain barrier (BBB) poses a major obstacle to delivering therapeutic agents to the central nervous system (CNS), driving the need for innovative drug delivery strategies. Among these, nanoparticles (NPs) hav…